Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	SC-PEG (Arm A)	119
Overall Study	STARTED	Oncaspar (Arm B)	121
Overall Study	Evaluable for Induction Events	SC-PEG (Arm A)	115
Overall Study	Evaluable for Induction Events	Oncaspar (Arm B)	115
Overall Study	Achieved Complete Remission	SC-PEG (Arm A)	109
Overall Study	Achieved Complete Remission	Oncaspar (Arm B)	114
Overall Study	Received Post-induction Asparaginase	SC-PEG (Arm A)	109
Overall Study	Received Post-induction Asparaginase	Oncaspar (Arm B)	114
Overall Study	Eligible	SC-PEG (Arm A)	119
Overall Study	Eligible	Oncaspar (Arm B)	120
Overall Study	COMPLETED	SC-PEG (Arm A)	87
Overall Study	COMPLETED	Oncaspar (Arm B)	99
Overall Study	NOT COMPLETED	SC-PEG (Arm A)	32
Overall Study	NOT COMPLETED	Oncaspar (Arm B)	22

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01574274/flow